Bavarian Nordic

Hejreskovvej 10A
DK-3490 Kvistgaard, Denmark

Bavarian Nordic News

Bavarian Nordic VP: Medical countermeasure development must advance

Monday, Nov 23, 2015 @ 12:33pm by BioPrepWatch Reports

The ability of the United States to prepare for and respond to biological threats heavily relies on further development of drug and vaccine medical countermeasures, an area requiring significantly more attention from the federal government, a Bavarian Nordic (BN) executive says.
Read More »

Bavarian Nordic initiates Sierra Leone Ebola vaccine study

Wednesday, Oct 14, 2015 @ 5:28pm by BioPrepWatch Reports

This study acts as a parallel track to similar studies being conducted in the United States, Africa and Europe. Studies in the U.K.
Read More »

Bavarian Nordic initiates Ebola vaccine study in Sierra Leone

Tuesday, Oct 13, 2015 @ 2:45pm by BioPrepWatch Reports

A safety and immunogenicity study for an Ebola virus candidate vaccine has been initiated in Sierra Leone, Bavarian Nordic announced Friday.
Read More »

Bavarian Nordic awarded $9 million Janssen contract

Tuesday, Sep 15, 2015 @ 9:20am by BioPrepWatch Reports

BARDA funds will be used to further develop possible Ebola vaccine boost regimen
Read More »

Bavarian Nordic Ebola treatment enters Phase I trials

Tuesday, Jan 6, 2015 @ 4:26pm by BioPrepWatch Reports

Bavarian Nordic announced on Tuesday that their MVA-BN Ebola vaccine regimen has entered the first phase of clinical trials.
Read More »

Bavarian Nordic begins trial of Ebola vaccine booster

Thursday, Dec 4, 2014 @ 4:13pm by BioPrepWatch Reports

An international biotechnology company announced Thursday that is has given the first human an Ebola vaccine booster to study the response of the drug.
Read More »